组别(n) | 时间 | ALT (U/L) | AST (U/L) | TBIL (μmol/L) | GGT (U/L) |
观察组(267) | 治疗前 | 46.02 ± 3.92 | 42.82 ± 2.91 | 24.87 ± 1.46 | 55.46 ± 11.43 |
| 治疗后 | 50.24 ± 4.32 | 46.03 ± 3.72 | 27.65 ± 2.13 | 59.43 ± 3.22 |
对照组(289) | 治疗前 | 45.89 ± 3.87 | 43.11 ± 1.76 | 24.90 ± 1.55 | 56.10 ± 11.84 |
| 治疗后 | 61.42 ± 5.06 | 58.83 ± 4.50 | 34.91 ± 1.93 | 67.32 ± 3.91 |
t1/P |
| 0.321/0.748 | 1.348/0.178 | 0.223/0.824 | 0.645/0.539 |
t2/P |
| 11.438/<0.001 | 10.746/<0.001 | 17.022/<0.001 | 5.286/<0.001 |
t3/P |
| 38.546/<0.001 | 51.440/<0.001 | 63.939/<0.001 | 14.228/<0.001 |
t4/P |
| 26.569/<0.001 | 34.664/<0.001 | 39.936/<0.001 | 24.629/<0.001 |